Press Release   Date Link  
           
  INTEGRATED BIOPHARMA ANNOUNCES CLOSING OF $11.7 MILLION REVOLVING CREDIT FACILITY AND REFINANCING OF SUBORDINATED DEBT   06/29/12 PDF  
           
  INTEGRATED BIOPHARMA, INC. ANNOUNCES VOLUNTARY DELISTING OF ITS COMMON STOCK   04/13/09 HTM  
           
  INTEGRATED BIOPHARMA, INC. ANNOUNCES RESIGNATION OF CHIEF EXECUTIVE OFFICER   04/08/09 HTM  
           
  Tax Basis Information - Distribution of iBioPharma Common Stock     [click here]  
           
           
 
 
225 Long Avenue, Hillside, NJ 07205 USA
Tel 973.926.0816  Fax 973.926.1735
Investor Relations 888.319.6962